Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BE Therapy

Financiado

Cerrado

A revolutionary digital therapeutics platform for personalized and effective neu...

A revolutionary digital therapeutics platform for personalized and effective neurocognitive rehabilitation Cognitive impairment causes decline in cognitive abilities, including memory and thinking skills. It is fast growing, and affects around 450 million people globally. The major causes of cognitive impairment are Traumatic Brain Inj... ver más

30/09/2019

Brainmarc

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

BRAINMARC LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 5 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-09-30

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

5 Participantes

Brainmarc

50.00K€ | Lider

AITODETEC

437.89K€ | Participante

COTERENA,

1.22M€ | Participante

GRG SOLUCIONES INFORMATICAS

204.50K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

INDIREA Individualised Diagnostics and Rehabilitation of Attention 4M€ Cerrado

MNeuronic A Mnemonic system based on stimulation free Neuroimaging 150K€ Cerrado

BabyMinder BabyMinder Automatic diagnosis of neurocognitive impairment... 150K€ Cerrado

GrayMatters for PTSD - GfP A NON-INVASIVE, ADAPTIVE DIGITAL THERAPEUTIC SOLUTION FOR PO... 4M€ Cerrado

CONTRAST An individually adaptable BNCI based remote controlled Cog... 4M€ Cerrado

NeMoRe NeuroModulation Rehabilitation. A neurofeedback and transcra... 165K€ Cerrado

Duración del proyecto: 3 meses Fecha Inicio: 2019-06-11
Fecha Fin: 2019-09-30

Líder del proyecto

BRAINMARC LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cognitive impairment causes decline in cognitive abilities, including memory and thinking skills. It is fast growing, and affects around 450 million people globally. The major causes of cognitive impairment are Traumatic Brain Injury (TBI), stroke, ageing, depression, anxiety and Attention-deficit/hyperactivity disorder (ADHD). Cognitive rehabilitation is a program to help brain-injured or otherwise cognitively impaired individuals to restore normal functioning, or to compensate for cognitive deficits. Nevertheless, the overall rehabilitation efficacy is surprisingly low (about 5%), even for patients with mild conditions. Multiple studies indicate that this stems from insufficient recruitment of patients’ brain engagement to the therapy. BE Therapy is a revolutionary digital therapeutics platform for personalised and effective neurocognitive rehabilitation. It consists of a wearable EEG device and a patient management system. During cognitive therapy, BE Therapy proprietary algorithms capture real-time brain engagement from EEG data. The patient management platform then autonomously adjusts the therapy to be most effective to the patient, maximizing brain engagement and dramatically improving cognitive therapy efficacy. This personalisation can be tweaked or supervised by an onsite or remote physician. Digitisation of the platform enables to optimise session frequencies and increase availability to serve more patients, thus maximising public health care system resources. Being a home-point-of-care solution, it reduces the costs and time associated with the rehabilitation. During the phase 1 feasibility study, Brainmarc will establish a sound go-to-market strategy and supply chain, and will outline further development plans. In the second phase of the innovation project, Brainmarc will optimize the device and treatment management system, perform clinical validation with European hospitals and rehabilitation centers, and obtain CE mark for market entry.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores